CordenPharma is one of the leading manufacturers of peptide Active Pharmaceutical Ingredients (APIs) with an unprecedented track record of experience in supporting our customers along the value chain ranging from early clinical to commercial in worldwide markets. Today we support more than 50 cGMP development projects targeting either New Chemical Entities or Generic development activities. Furthermore our expertise covers ancillary areas such as conjugation to carbohydrates, lipids and pegylation. Most notably is the fact that scale does not represent any limitation at CordenPharma. We are the only company in the world who has sufficient capacity to produce peptide APIs from gram scale up to annual quantities of hundreds of kilograms. This is underlined by our experience in the manufacturing of Fuzeon® (enfuvirtide), with CordenPharma being the only company to have produced metric tons of this complex peptide.
As the volume leader in custom peptide production with automated peptide synthesizers ranging from 12 L to 10,000 L, CordenPharma is committed to addressing complex solvent handling, recovery and recycling logistics.
Furthermore, CordenPharma’s combined large-scale peptide production capabilities also include preparative HPLC, lyophylization equipment, spraydrying, as well as proprietary peptide precipitation know-how for cost effective final-step peptide isolation.
CordenPharma additionally provides expertise in scaling complex peptides with multiple disulfide bridges or particularly long sequences (up to 60 amino acid residues) as well as lipo and carbohydrate conjugates.
CordenPharma’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs), Finished Dosage and Packaging in our network of facilities allows clients full access to integrated services resulting in a simplified supply chain, reduced risk and cost associated with technology transfers, and ultimately faster production and delivery timelines.